# Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure

> **NCT02961829** · NA · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 30 (actual)

## Conditions studied

- Chronic Infection
- HIV

## Interventions

- **DRUG:** Maraviroc
- **DRUG:** Dolutegravir
- **BIOLOGICAL:** Dendritic Cell Vaccine
- **DRUG:** Auranofin
- **DRUG:** Sirtuin Histone deacetylase inhibitor

## Key facts

- **NCT ID:** NCT02961829
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2019-03
- **Final completion:** 2020-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-07-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02961829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02961829, "Multi Interventional Study Exploring HIV-1 Residual Replication: a Step Towards HIV-1 Eradication and Sterilizing Cure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02961829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*